View of From the emergence to the end of Anvisa’s prior consent: a critical analysis of pharmaceutical patenting in Brazil

Return to Issue Details From the emergence to the end of Anvisa’s prior consent: a critical analysis of pharmaceutical patenting in Brazil Download Download PDF